What did Clearlake Capital Group, LP pay for ProVation Medical?

Clearlake Capital Group, LP acquired ProVation Medical for $180.0M in 2018 (6.0x EBITDA), equivalent to 2.30x revenue. Target revenue was approximately $78.0M. Target EBITDA was approximately $30.0M.

What does ProVation Medical do?

ProVation Medical is a healthcare it business.

What multiple did Clearlake Capital Group, LP pay for ProVation Medical?

6.0x EBITDA and 2.30x revenue, based on disclosed deal value of $180.0M and disclosed financials.

M&A TRANSACTION · 2018

ProVation Medical acquired by Clearlake Capital Group, LP

$180.0M· 6.0x EBITDA· 2.30x revenue

Target

ProVation Medical

Acquirer

Clearlake Capital Group, LP

Private Equity buyer

Disclosed financials at time of acquisition

Revenue

$78.0M

EBITDA

$30.0M

Deal Value

$180.0M

EV/EBITDA

6.0x

Context

This $180.0M acquisition of ProVation Medical by Clearlake Capital Group, LP sits in the healthcare it sub-vertical. The 6.0x EBITDA multiple paid in 2018 can be compared against the population median for healthcare it transactions of similar size on our Healthcare It valuation hub. Clearlake Capital Group, LP is acquiring as a private equity buyer; see how PE acquirers typically price healthcare it businesses on our Healthcare It PE buyer-pool page.

Source

Data sourced from Press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own healthcare it

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the ProVation Medical acquisition.

Citation: ExitValue.ai. (2018). ProVation Medical acquired by Clearlake Capital Group, LP. https://exitvalue.ai/deals/provation-medical-acquired-by-clearlake-capital-group-lp-hc-2018-0180